The article discusses the challenges of an Alzheimer's diagnosis, highlighting the staggering global incidence of approximately seven million new cases annually. Previously viewed as an inevitable aspect of aging, Alzheimer's is now understood to have treatable aspects. Emerging therapies target amyloid-β plaques to decelerate cognitive decline, while blood tests provide crucial distinctions between Alzheimer's and other forms of dementia. Ongoing research is uncovering genetic influences and potential pathogen roles behind the disease, promising better treatments and preventative strategies with advances in scientific understanding. The article reveals a hopeful shift in managing Alzheimer's.
Advances in diagnosis and treatment mean that rapid cognitive decline won't necessarily follow hot on the heels of a diagnosis.
Although Alzheimer's is not yet curable, a handful of treatments can slow its progression, and much work is being done to try to further turn the tide.
A major breakthrough of the past five years is the development of blood tests that can distinguish Alzheimer's from other forms of dementia.
Scientists' understanding of Alzheimer's continues to grow, leading to new avenues for treatment and prevention, including insights from unique genetic cases.
Collection
[
|
...
]